clinical course patients cystic fibrosis cf functionally similar mutations cf transmembrane conductance regulator gene variable relate secondary genetic environmental factors examined hypothesis polymorphisms certain inflammatory mediator regulatory genes affect clinical outcome influencing degree damage studying possible association clinical outcome angiotensin enzyme ace cytokine genotypes amplification refractory mutation chain reaction using stored dna NUMBER white patients cf ultrasound features cirrhosis occurred frequently patients dd ii ace genotype odds ratio NUMBER confidence interval NUMBER NUMBER NUMBER significant pulmonary dysfunction age fev1 NUMBER associated ace genotype NUMBER NUMBER NUMBER transforming growth genotype NUMBER NUMBER NUMBER age colonization pseudomonas aeruginosa NUMBER NUMBER NUMBER conclude ace genotype predicts patients cf increased chance developing portal hypertension ace genotypes secondary genetic factors contributing pulmonary dysfunction patients end organ converting polymerase high producer low producer high producer factor beta1 high producer high producer tgf beta1